文献速递性腺与生殖内分泌肥胖与代谢综合征

内源性激素与绝经过渡期HDL新指标的相关性:SWAN HDL研究

Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该纵向分析纳入463名基线平均年龄50.2岁的社区女性,探讨雌二醇(E2)和促卵泡激素(FSH)与HDL新指标的关系,并分析距最终月经(FMP)时间对这种关系的影响。结果发现E2与HDL颗粒大小、大HDL颗粒、胆固醇流出能力(HDL-CEC)和HDL甘油三酯正相关,与中等HDL颗粒负相关;FSH与总HDL颗粒和中等HDL颗粒正相关,与HDL大小、大HDL颗粒和每颗粒HDL-CEC负相关。部分关联受距FMP时间影响。

要点

  • E2与HDL大小、大HDL颗粒、HDL-CEC和HDL-Tg正相关,与中等HDL颗粒负相关。
  • FSH与总HDL颗粒和中等HDL颗粒正相关,与HDL大小、大HDL颗粒和每颗粒HDL-CEC负相关。
  • E2与HDL-Tg的正关联在FMP后2年强于之前;FSH与总HDL颗粒和HDL大小的关联仅在绝经后显现。

核心结论

  • E2和FSH与部分HDL新指标的关联受距绝经时间的影响,提示绝经启动时机可能改变激素对HDL代谢的作用。

研究设计与样本

  • 研究为SWAN HDL研究的纵向分析,纳入463名社区女性,基线平均年龄50.2(2.7)岁。

主要发现

  • 多变量分析中,E2与HDL大小、大HDL颗粒、HDL-CEC和HDL-Tg正相关,与中等HDL颗粒负相关(P值<0.05)。
  • E2与HDL-Tg的正关联在FMP后2年强于之前(交互P=0.031)。
  • FSH与总HDL颗粒和中等HDL颗粒正相关,与HDL大小、大HDL颗粒和每颗粒HDL-CEC负相关(P值<0.05)。
  • FSH与总HDL颗粒正相关及与HDL大小负相关仅在绝经时/后显现(交互P值<0.05)。

临床怎么用

  • 临床评估绝经过渡期女性HDL功能时,需结合距FMP时间解读E2和FSH与HDL新指标的关系。
  • 未来需检验相对于绝经晚期启动激素治疗是否对HDL颗粒脂质含量有不利影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Novel metrics of high-density lipoprotein (HDL) (subclasses, lipid content, and function) may improve characterization of the anti-atherogenic features of HDL. In midlife women, changes in these metrics vary by time relative to the final menstrual period (FMP), supporting a contribution of estradiol (E2) and follicle-stimulating hormone (FSH). OBJECTIVE: We tested associations of endogenous E2 and FSH with novel HDL metrics and assessed whether these associations varied by time relative to FMP. METHODS: This study was a longitudinal analysis from the Study of Women's Health Across the Nation (SWAN) HDL study, using a community-based cohort of 463 women, baseline mean age 50.2 (2.7) years. The main outcome measures were HDL cholesterol efflux capacity (HDL-CEC), HDL phospholipids (HDL-PL), HDL triglycerides (HDL-Tg), HDL particles (HDL-P), HDL size, and HDL cholesterol (HDL-C). RESULTS: In multivariable analyses, E2 was positively associated with HDL size, large HDL-P, HDL-CEC, and HDL-Tg, but negatively with medium HDL-P (P values < 0.05). The positive association between E2 and HDL-Tg was stronger 2 years post-FMP than before, (interaction P = 0.031). FSH was positively related to total and medium HDL-P, but negatively to HDL size, large HDL-P, and HDL-CEC per particle (P values < 0.05). Associations of higher FSH with greater total HDL-P and smaller HDL size were only evident at/after menopause (interaction P values < 0.05). CONCLUSION: Some of the associations linking E2 and FSH with novel HDL metrics were vulnerable to time relative to menopause onset. Whether a late initiation of hormone therapy relative to menopause could have a detrimental effect on lipid content of HDL particles should be tested in the future.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. El Khoudary SR, Nasr A, Billheimer J, et al. Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study. J Clin Endocrinol Metab. 2022. PMID: 34390340. doi:10.1210/clinem/dgab595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。